Induced pluripotent stem cell line, ICAGi001-A, derived from human skin fibroblasts of a patient with 2p25.3 deletion and 2p25.3-p23.3 inverted duplication
В новом выпуске журнала "Stem Cell Research" за 2019 год опубликована статья сотрудников лаборатории цитогенетики НИИ медицинской генетики Томского НИМЦ в соавторстве с томскими, новосибирскими и московскими коллегами "Induced pluripotent stem cell line, ICAGi001-A, derived from human skin fibroblasts of a patient with 2p25.3 deletion and 2p25.3-p23.3 inverted duplication"
Khabarova A.A.a, Pristyazhnyuk I.E., Nikitina T.V., Gayner T.A., Torkhova N.B.,Skryabin N.A., Kashevarova A.A., Babushkina N.P., Markova Zh.G., Minzhenkova M.E.,Nazarenko L.P., Shilova N.V., Shorina A.R., Lebedev I.N., Serov O.L. Induced pluripotent stem cell line, ICAGi001-A, derived from human skin fibroblasts of a patient with 2p25.3 deletion and 2p25.3-p23.3 inverted duplication. // Stem Cell Research (34) 2019 101377.
Abstract
Skin fibroblasts from a patient with developmental delay and chromosome 2p25.3 deletion syndrome were reprogrammed into induced pluripotent stem cells (iPSCs) and the clonal stem cell line ICAGi001-A (iTAF9-11) was established. ICAGi001-A pluripotency was demonstrated in vitro by three germ layer differentiation capacity. This line is a good model for studying of the developmental delay and brain disorder.
doi.org/10.1016/j.scr.2018.101377
просмотров: 2634, опубликовано: 22.01.2019
